Clinical Trial Update: Tubular Markers in Response to Saxagliptin Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update examining tubular markers in response to saxagliptin therapy for type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)

Snippet

Sponsor: Beni-Suef University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED